Redeye provides a short comment on the trading update from Cheffelo released earlier this morning.
Redeye retains its Q4 and 2025 forecasts for Transtema.
Q4 report due 18 February We forecast net sales of SEK 189m, EBITA of SEK 27m Trading near low end o...
Redeye comments on the new data from the triple combination study of BI-1206 and the phase I monothe...
Redeye comments on the organisational changes and their implications on forecasts and makes a previe...
Eolus signs agreement to sell 100 MW battery storage project Estimated EV for the project in the USD...
Q4 number of subsscribers 2% above ABGSCe driven by premium The beat would lift service revenue by N...
Smart Eye has announced an agreement to license iris recognition technology from Fingerprint Cards f...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) offentliggjorde den 31 december...
Redeye leaves a comment on Xbrane’s press release stating that it now has re-submitted its Lucentis ...
Redeye provides a comment on today's news in Scandinavian ChemoTech regarding the separation of Huma...
IT market weakness hitting Proact After showing good resilience so far this year, Proact had to prof...
Nettoomsättningen uppgick till 53,1 MSEK (50,0) i det andra kvartalet (aug-okt) i Purefuns brutna rä...
Redeye provides a brief comment on Mendus announcing that Institut Bergonié terminated the collabora...
Gapwaves entered a product sales agreement with Smartmicro worth SEK90m, with an expected ramp-up st...
